Dr. Kyoungmin Park focuses on investigating the molecular mechanisms underlying insulin’s action on the vascular wall and developing new therapeutic drugs for macrovascular complications, atherosclerosis in Type 2 diabetes. Additionally, working to determine the role of autoimmunity or autoimmune disease in the severity and development of atherosclerosis in Type 1 diabetes, diabetes-related disease, including cardiovascular disease.
University of Oklahoma Health Sciences Center
ADA Fellowship
News Related to Kyoungmin Park
Joslin Diabetes Center researchers studied the relationship among diabetes, fat and cardiovascular disease, finding that blood vessels are a key regulator of brown fat and energy metabolism.
Read more on Study Reverses Long-Held Ideas About Relationship Among Diabetes, Fat and Cardiovascular Disease
Research may show way to minimize complications after heart treatment
BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment
Research may show way to minimize complications after heart treatment
Insulin may drive the clogging of stents that often follows coronary angioplasties in people with diabetes. BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart...
Read more on Research may show way to minimize complications after heart treatment